Suppr超能文献

终末期肾病患者的制动所致症状性高钙血症

Symptomatic hypercalcemia of immobilization in a patient with end-stage renal disease.

作者信息

Gopal H, Sklar A H, Sherrard D J

机构信息

Department of Medicine, United Health Services Hospitals, Binghamton, NY, USA.

出版信息

Am J Kidney Dis. 2000 May;35(5):969-72. doi: 10.1016/s0272-6386(00)70272-1.

Abstract

The phenomenon of hypercalcemia in immobilization is well known, but there is limited awareness of the potential for this complication in patients with end-stage renal disease (ESRD) on maintenance hemodialysis with reduced capacity for disposition of calcium. We describe such a patient who showed a calcemic response to just 3 days of immobilization in the setting of an acute illness marked by coma. Despite intensive initial therapy for hypercalcemia, including withdrawal of all calcium products and daily hemodialysis treatments using low calcium baths, her serum calcium rose to 14.0 mg/dL during the hospitalization; this metabolic abnormality appeared to perpetuate her stuporous state. Mobilization as an outpatient was the most effective therapy. Extensive testing was performed to rule out other causes for this patient's hypercalcemia. Greater recognition of acute hypercalcemia in patients with ESRD immobilized by various illnesses would preclude unnecessarily expensive and invasive testing for other causes of hypercalcemia.

摘要

制动导致高钙血症的现象已广为人知,但对于接受维持性血液透析且钙代谢能力下降的终末期肾病(ESRD)患者发生这种并发症的可能性,人们的认识有限。我们描述了这样一位患者,在以昏迷为特征的急性疾病背景下,仅制动3天就出现了血钙反应。尽管对高钙血症进行了强化初始治疗,包括停用所有钙制品以及使用低钙透析液进行每日血液透析治疗,但她在住院期间血清钙仍升至14.0mg/dL;这种代谢异常似乎使她一直处于昏迷状态。门诊活动是最有效的治疗方法。进行了广泛的检查以排除该患者高钙血症的其他原因。对于因各种疾病而制动的ESRD患者中急性高钙血症有更多认识,将避免对高钙血症的其他原因进行不必要的昂贵且有创的检查。

相似文献

1
Symptomatic hypercalcemia of immobilization in a patient with end-stage renal disease.
Am J Kidney Dis. 2000 May;35(5):969-72. doi: 10.1016/s0272-6386(00)70272-1.
2
Immobilization-related hypercalcemia after renal failure in burn injury.
Endocr Pract. 2002 May-Jun;8(3):213-6. doi: 10.4158/EP.8.3.213.
3
An unrecognized cause of recurrent hypercalcemia: immobilization.
South Med J. 2006 Apr;99(4):371-4. doi: 10.1097/01.smj.0000210142.76331.b4.
4
Using denosumab to treat immobilization hypercalcemia in a post-acute care patient.
J Clin Endocrinol Metab. 2014 Oct;99(10):3531-5. doi: 10.1210/jc.2013-4205. Epub 2014 Jul 17.
6
[Immobilization hypercalcemia as a complication of polyneuropathy].
Nervenarzt. 2000 Aug;71(8):655-9. doi: 10.1007/s001150050642.
8
Denosumab for treatment of immobilization-related hypercalcemia in a patient with end-stage renal disease.
CEN Case Rep. 2017 May;6(1):111-114. doi: 10.1007/s13730-017-0254-5. Epub 2017 Feb 27.

引用本文的文献

1
Denosumab for treatment of immobilization-related hypercalcemia in a patient with end-stage renal disease.
CEN Case Rep. 2017 May;6(1):111-114. doi: 10.1007/s13730-017-0254-5. Epub 2017 Feb 27.
2
Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure.
Clin Kidney J. 2012 Dec;5(6):566-71. doi: 10.1093/ckj/sfs116. Epub 2012 Oct 7.
3
Treatment of immobilization-related hypercalcaemia with denosumab.
Clin Kidney J. 2012 Dec;5(6):491-5. doi: 10.1093/ckj/sfs133. Epub 2012 Nov 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验